Febuxostat CAS 144060-53-7 Tsarkake>99.0% (HPLC) Kamfanin API
Ruifu Chemical Supply Febuxostat Matsakaici masu dangantaka:
Febuxostat CAS 144060-53-7
Ethyl 2-Chloroacetoacetate CAS 609-15-4
4-Hydroxythiobenzamide CAS 25984-63-8
Ethyl 2- (3-Cyano-4-Hydroxyphenyl) -4-Methyl-1,3-Thiazole-5-Carboxylate CAS 161798-02-3
Ethyl 2- (3-Cyano-4-Isobutoxyphenyl) -4-Methyl-5-Thiazolecarboxylate CAS 160844-75-7
Ethyl 2- (3-Formyl-4-Hydroxyphenyl) -4-Methylthiazole-5-Carboxylate CAS 161798-01-2
Ethyl 2- (3-Formyl-4-Isobutoxyphenyl) -4-Methylthiazole-5-Carboxylate CAS 161798-03-4
Ethyl 2- (4-Hydroxyphenyl) -4-Methylthiazole-5-Carboxylate CAS 161797-99-5
Sunan Sinadari | Febuxostat |
Makamantu | 2- (3-Cyano-4-Isobutoxyphenyl) -4-Methylthiazole-5-Carboxylic Acid |
Lambar CAS | 144060-53-7 |
Matsayin Hannun jari | A cikin Hannun jari, Ma'aunin samarwa Har zuwa Ton |
Tsarin kwayoyin halitta | Saukewa: C16H16N2O3S |
Nauyin Kwayoyin Halitta | 316.38 |
Matsayin narkewa | 207.0 zuwa 211.0 ℃ |
Yawan yawa | 1.31± 0.1 g/cm3 |
Alamar | Ruifu Chemical |
Abu | Ƙayyadaddun bayanai |
Bayyanar | Fari zuwa Kashe-White Crystalline Foda |
Ganewa | HPLC/IR |
Tsarkake / Hanyar Bincike | > 99.0% (HPLC akan busasshiyar tushe) |
Asara akan bushewa | <1.00% (Busar da shi a 105 ℃ a cikin na'urar busar da iska ta lantarki har sai nauyi mai tsayi) |
Ragowa akan ƙonewa | <0.10% |
Abubuwa masu alaƙa | |
Matsakaicin Tsabtace Guda Daya | <0.30% |
Jimlar ƙazanta | <1.00% |
Chlorides | <0.04% |
Karfe masu nauyi | <20ppm |
Matsayin Gwaji | Matsayin Kasuwanci |
Amfani | API |
Kunshin: Bottle, Aluminum tsare jakar, 25kg / kwali Drum, ko bisa ga abokin ciniki ta bukata
Yanayin Ajiya:Ajiye a cikin kwantena da aka rufe a wuri mai sanyi da bushe;Kare daga haske da danshi
Febuxostat (CAS: 144060-53-7), wanda aka sayar a ƙarƙashin alamar sunan Uloric da Adenuric da sauransu, magani ne da ake amfani da shi na dogon lokaci don magance gout saboda yawan matakan uric acid.Gabaɗaya ana ba da shawarar kawai ga mutanen da ba za su iya ɗaukar allopurinol ba.Lokacin da aka fara farawa, ana ba da shawarar magunguna irin su NSAIDs don hana gout flares.Ana dauka da baki.An amince da Febuxostat don amfani da magani a cikin Tarayyar Turai a cikin 2008 da kuma a Amurka a cikin 2009. Ana amfani da Febuxostat don magance gout da hyperuricemia na kullum.Febuxostat yawanci ana ba da shawarar kawai ga mutanen da ba za su iya jure wa allopurinol ba.